From bench to bedside: What to consider when translating to clinical-grade cytokines [WEBINAR] 

For more information, visit: www.miltenyibiotec.com/DE-en/... Choosing the most suitable clinical-grade cytokines for a particular process is a challenging task, and you should be aware of a number of caveats. In this webinar, you will learn what to look for when translating to GMP-grade cytokines and how to avoid common mistakes. You will gain a better understanding of how cytokines affect complex manufacturing processes. Keep learning and join the cell therapy success stories that are making headlines every day.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.